Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fickert

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Human Virology|April 9, 1999
Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapyH H Kessler, K Pierer, B I Santner, et al.
Gastroenterology|December 1, 1996
Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutationP Fickert, H Ramschak, L Kenner, et al.
Journal of Viral Hepatitis|April 12, 2000
Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis CP Ferenci, R Stauber, P Steindl-Munda, et al.
Gastroenterology|July 5, 2001
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liverP Fickert, G Zollner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseasesG Zollner, P Fickert, R Zenz, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2001
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study GroupP Ferenci, R Stauber, P Steindl-Munda, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocationF Rainer, A Horvath, T D Sandahl, et al.
Alimentary Pharmacology & Therapeutics|September 6, 2016
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosisA Horvath, B Leber, B Schmerboeck, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Human Virology|April 9, 1999
Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapyH H Kessler, K Pierer, B I Santner, et al.
Gastroenterology|December 1, 1996
Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutationP Fickert, H Ramschak, L Kenner, et al.
Journal of Viral Hepatitis|April 12, 2000
Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis CP Ferenci, R Stauber, P Steindl-Munda, et al.
Gastroenterology|July 5, 2001
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liverP Fickert, G Zollner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseasesG Zollner, P Fickert, R Zenz, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2001
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study GroupP Ferenci, R Stauber, P Steindl-Munda, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocationF Rainer, A Horvath, T D Sandahl, et al.
Alimentary Pharmacology & Therapeutics|September 6, 2016
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosisA Horvath, B Leber, B Schmerboeck, et al.
Pageof 3